Last reviewed · How we verify

NCT06728215

Capacitive-Resistive Energy Transfer (CRET) for the Treatment of Low Back Pain

Completed Last updated 12 February 2025
What this trial tests

trial testing CRET 1 in Low Back Pain in 52 participants. Completed in 1 June 2024.

Timeline
1 October 2023
Primary endpoint
1 June 2024
1 June 2024

Quick facts

Lead sponsorD&V FARMA srl
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date1 October 2023
Primary completion1 June 2024
Estimated completion1 June 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

D&V FARMA srl

Who can join

18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective observational study compares the effectiveness of two CRET therapies in adults with physical dysfunction. It evaluates whether the UNIQ electrode Fisiowarm 7.0 improves lumbar ROM (Schober test) and reduces pain (VAS scores) more effectively than the classical methodology, with assessments at baseline (T0) and two weeks (T1).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of UNIQ and classic unipolar electrodes in TECAR therapy for low back pain: a retrospective cohort study.
    Giovanelli M, Papaianopol A. · · 2026 · PMID 42079989 · DOI 10.1589/jpts.38.193

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other D&V FARMA srl trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06728215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing